BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.3052
-0.0948 (-23.70%)
Dec 24, 2025, 12:27 PM EST
BioCorRx Market Cap
BioCorRx has a market cap or net worth of $7.41 million as of December 24, 2025. Its market cap has decreased by -25.04% in one year.
Market Cap
7.41M
Enterprise Value
10.64M
Revenue
948.36K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since November 1, 2011, BioCorRx's market cap has increased from 2.26M to 7.41M, an increase of 227.56%. That is a compound annual growth rate of 8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 7.41M | 48.90% |
| Dec 31, 2024 | 4.98M | -26.29% |
| Dec 29, 2023 | 6.75M | -9.64% |
| Dec 30, 2022 | 7.47M | -74.20% |
| Dec 31, 2021 | 28.98M | 462.57% |
| Dec 31, 2020 | 5.15M | -64.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 722.39M |
| Elite Pharmaceuticals | 515.15M |
| Northwest Biotherapeutics | 401.29M |
| American Oncology Network | 394.40M |
| CytoDyn | 357.58M |
| Silence Therapeutics | 304.66M |
| Nika Pharmaceuticals | 291.10M |